Supporting data for "Adjuvant berberine for the management of antipsychotic-associated metabolic syndrome in patients with chronic schizophrenia: a literature review and a randomised controlled trial"

This is a dataset of the clinical trial "Berberine for antipsychotic-induced weight gain and metabolic syndrome: a randomised controlled trial". The demographic and clinical characteristics of 113 recruited subjects, as well as their study outcomes, are included in spreadsheets.